APPLICATION
ANDA210897
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-09
LATEST ACTION
2021-03-29
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription
Products
BUDESONIDEPrescription
BUDESONIDE 0.5MG/2ML · SUSPENSION · INHALATION
Approval history
2021-03-29Labeling · Supplement 2 · standardAP
2018-11-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.